Science Links Japan | Clinical Trial of Hydrogel Dressing (NMD-101) on Second-Degree Burns, Split-Thickness Skin Donor Sites, and Skin Defect Injuries.

Clinical Trial of Hydrogel Dressing (NMD-101) on Second-Degree Burns, Split-Thickness Skin Donor Sites, and Skin Defect Injuries.

Accession number;02A0900959

Title;Clinical Trial of Hydrogel Dressing (NMD-101) on Second-Degree Burns, Split-Thickness Skin Donor Sites, and Skin Defect Injuries.

Author;AIKAWA NAOKI(Keiodai I Kyukyubu) NOZAKI MOTOHIRO(Tokyo Women's Med. Coll., Fac. of Med.) TAKUMA KIYOTSUGU(Saiseikaikanagawakenbyoin Kyukyubu) AOKI KATSUNORI(Keiodai I Kyukyubu) YAMAZAKI MOTOYASU(Keiodai I Kyukyubu) KIKUCHI YUJI(Tokyo Women's Med. Coll., Fac. of Med.) TANABE YUMI(Tokyo Women's Med. Coll., Fac. of Med.) YUKIOKA TETSUO(Saiseikaikanagawakenbyoin Kyukyubu) SEKINE KAZUHIKO(Saiseikaikanagawakenbyoin Kyukyubu)

Journal Title;Japanese Pharmacology & Therapeutics

Journal Code:Z0947A

ISSN:0386-3603

VOL.30;NO.10;PAGE.863-874(2002)

Figure&Table&Reference;FIG.4, TBL.12, REF.10

Pub. Country;Japan

Language;Japanese

Abstract;In order to assess the clinical effectiveness and safety of Hydrogel dressing, NMD-101 (Nichiban Co., Ltd.), for the treatment of superficial skin wounds, the dressing has been applied to 30 subjects of either second degree burns, split-thickness skin donor sites, or skin defect injuries, and the clinical effects were examined. NMD-101 was applied on a wound and the wound had been observed for up to 3 weeks. The efficacy, usability, safety and the usefulness were evaluated. In efficacy evaluation, NMD-101 was "very effective" or "effective" in 83% of the patients. The usability was evaluated as "very good" or "good" in 90%. In 90% of the patients, NMD-101 was judged as "safe", and in the remaining patients, the judgement was "mostly safe". The overall usefulness was judged from the efficacy, usability, and safety, and in 83% of the patients, the overall usefulness was judged to be "very useful". (author abst.)